Breaking News Instant updates and real-time market news.

MRK

Merck

$83.45

0.08 (0.10%)

16:15
08/15/19
08/15
16:15
08/15/19
16:15

Merck initiated with an Outperform at SVB Leerink

SVB Leerink analyst Daina Graybosch initiated Merck with an Outperform rating and $103 price target.

  • 09

    Sep

  • 16

    Sep

  • 20

    Sep

  • 02

    Oct

  • 29

    Oct

MRK Merck
$83.45

0.08 (0.10%)

07/11/19
RAJA
07/11/19
NO CHANGE
RAJA
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
After multiple media outlets, including Politico, reported that the Trump Administration has decided to withdraw the drug rebate rule, Raymond James analyst Chris Meekins called the news "a win" for pharmacy benefit managers and drug distributors and "a slight negative" for the pharmaceutical makers. The cost of the proposal to the government was ultimately too high with little guarantee that list prices would go down, said Meekins. However, President Trump hinted something "major" on drug pricing was coming over the next week during his kidney care speech and the analyst thinks the President is planning to move forward with an executive order on pricing. Publicly traded pharmaceutical distributors include McKesson (MCK), Cardinal Health (CAH), Amerisource (ABC) and Patterson (PDCO). Owners of pharmacy benefit managers include CVS Health (CVS), UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI). Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/17/19
RAJA
07/17/19
NO CHANGE
RAJA
Investors shouldn't overreact to drug proposal headlines, says Raymond James
Raymond James analyst Chris Meekins noted that President Donald Trump has indicated an Executive Order on drug pricing is coming soon, but he believes investors "should be cautious not to overreact" to drug related proposal headlines as he "cannot think of a single proposal that was finalized and also survived a court challenge resulting in a negative impact on earnings" yet from the Trump Administration. Given the history of the current White House to date, Meekins said he is increasingly skeptical the Administration will get anything meaningful finalized and overcome legal challenges that will impact drugmakers' earnings before the 2020 election, he tells investors in a healthcare policy note. Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/22/19
OPCO
07/22/19
DOWNGRADE
OPCO
Perform
Oppenheimer downgrades Intec Pharma after 'major setback' of trial miss
As previously reported, Oppenheimer analyst Jay Olson downgraded Intec Pharma (NTEC) to Perform from Outperform after the company announced "a major setback" as the ACCORDANCE study did not achieve statistical superiority to Sinemet on the primary endpoint of reduction in daily OFF time. He noted that the company still has additional opportunities with other drugs, including proprietary partnerships with Novartis (NVS) and Merck (MRK), but said the read across from AP-CD/LD to other AP applications in different diseases is uncertain following this morning's news.
08/07/19
ARGS
08/07/19
NO CHANGE
Target $105
ARGS
Buy
Merck price target raised to $105 from $95 at Argus
Argus analyst David Toung raised his price target on Merck to $105 and kept his Buy rating after its "strong" Keytruda-driven Q2 earnings beat, also boosting his FY19 and FY20 EPS view by 16c and 10c to $4.89 and $5.35 respectively. The analyst sees Merck's "blockbuster" Keytruda drug on track for additional indications in the U.S., Japan, China and Europe, with additional growth drivers coming from its Gardasil, Bridion, Lynparza, and Lenvima programs.

TODAY'S FREE FLY STORIES

HTBK

Heritage Commerce

$11.52

-0.08 (-0.69%)

16:54
08/20/19
08/20
16:54
08/20/19
16:54
Hot Stocks
Heritage Commerce receives regulatory approval for merger »

Heritage Commerce, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

AMCR

Amcor

$9.99

-0.12 (-1.19%)

16:53
08/20/19
08/20
16:53
08/20/19
16:53
Earnings
Amcor sees FY20 adjusted constant currency EPS growth of approximately 5%-10% »

For the 2020 fiscal year,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

S

Sprint

$6.80

-0.155 (-2.23%)

16:50
08/20/19
08/20
16:50
08/20/19
16:50
Options
Sprint put spread is largest block on lightest volume day of the month »

Sprint put spread is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CAH

Cardinal Health

$43.74

0.26 (0.60%)

16:49
08/20/19
08/20
16:49
08/20/19
16:49
Syndicate
Breaking Syndicate news story on Cardinal Health »

Cardinal Health files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

DIS

Disney

$135.08

-0.25 (-0.18%)

, SNE

Sony

$55.69

-0.02 (-0.04%)

16:46
08/20/19
08/20
16:46
08/20/19
16:46
Periodicals
Disney-Sony dispute ends Feige's involvement with 'Spider-Man,' Deadline says »

Marvel Studios president…

DIS

Disney

$135.08

-0.25 (-0.18%)

SNE

Sony

$55.69

-0.02 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$53.38

-1.42 (-2.59%)

16:44
08/20/19
08/20
16:44
08/20/19
16:44
Hot Stocks
AIG names Sabra Purtill as Deputy CFO, Head of Treasury »

American International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 18

    Sep

AMCR

Amcor

$9.99

-0.12 (-1.19%)

16:41
08/20/19
08/20
16:41
08/20/19
16:41
Hot Stocks
Amcor declares quarterly dividend of 12c per share »

The Amcor Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

KLAC

KLA-Tencor

$140.38

-0.06 (-0.04%)

16:41
08/20/19
08/20
16:41
08/20/19
16:41
Hot Stocks
KLA-Tencor officer Amichai Steimberg sells over $1.2M in company shares »

KLA-Tencor officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

AMCR

Amcor

$9.99

-0.12 (-1.19%)

16:39
08/20/19
08/20
16:39
08/20/19
16:39
Hot Stocks
Amcor approves $500M share buyback »

Amcor CEO Ron Delia said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

16:38
08/20/19
08/20
16:38
08/20/19
16:38
General News
API crude inventories for week of August 16 »

API reports that crude…

JKHY

Jack Henry

$140.79

-0.72 (-0.51%)

16:36
08/20/19
08/20
16:36
08/20/19
16:36
Earnings
Jack Henry & Associates reports Q4 EPS 79c, consensus 77c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 11

    Sep

  • 12

    Sep

CECO

Career Education

$21.94

-0.05 (-0.23%)

16:35
08/20/19
08/20
16:35
08/20/19
16:35
Hot Stocks
Career Education VP Michele Peppers sells over $221K in company shares »

Career Education VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 25

    Sep

  • 26

    Sep

ALC

Alcon

$62.45

0.66 (1.07%)

16:35
08/20/19
08/20
16:35
08/20/19
16:35
Earnings
Breaking Earnings news story on Alcon »

Alcon sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 09

    Sep

NDSN

Nordson

$135.43

-1.79 (-1.30%)

16:34
08/20/19
08/20
16:34
08/20/19
16:34
Hot Stocks
Nordson expects flat to modest organic sales growth in FY19 »

Expects an unfavorable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

HD

Home Depot

$217.14

9.165 (4.41%)

, KSS

Kohl's

$44.87

-3.33 (-6.91%)

16:34
08/20/19
08/20
16:34
08/20/19
16:34
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

The S&P 500 halted a…

HD

Home Depot

$217.14

9.165 (4.41%)

KSS

Kohl's

$44.87

-3.33 (-6.91%)

TJX

TJX

$51.55

(0.00%)

ELAN

Elanco

$27.25

-2.57 (-8.62%)

BAYRY

Bayer

$0.00

(0.00%)

SABR

Sabre

$23.73

-0.2 (-0.84%)

FB

Facebook

$183.76

-2.46 (-1.32%)

ENDP

Endo

$3.02

0.47 (18.43%)

MDT

Medtronic

$106.91

2.76 (2.65%)

SRPT

Sarepta

$101.90

-18.26 (-15.20%)

FN

Fabrinet

$46.40

-10 (-17.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 21

    Aug

  • 22

    Aug

  • 04

    Sep

  • 09

    Sep

  • 11

    Sep

  • 15

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Oct

NDSN

Nordson

$135.43

-1.79 (-1.30%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Hot Stocks
Breaking Hot Stocks news story on Nordson »

Nordson reports FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TOL

Toll Brothers

$36.91

0.52 (1.43%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Earnings
Toll Brothers sees FY19 deliveries 7,800-8,100 units »

The company expects FY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

ALC

Alcon

$62.45

0.66 (1.07%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Earnings
Alcon reports Q2 core EPS 47c, consensus 48c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 09

    Sep

ORLY

O'Reilly Automotive

$383.21

-2.42 (-0.63%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Hot Stocks
O'Reilly Automotive to acquire Mayasa Auto Parts, terms not disclosed »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$135.43

-1.79 (-1.30%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Earnings
Nordson reports Q3 GAAP EPS $1.62, consensus $1.81 »

Reports Q3 revenue $560M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TOL

Toll Brothers

$36.91

0.52 (1.43%)

16:32
08/20/19
08/20
16:32
08/20/19
16:32
Earnings
Toll Brothers reports Q3 EPS $1.00, consensus 82c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

16:30
08/20/19
08/20
16:30
08/20/19
16:30
Options
Preliminary option volume of 15.2M today »

Preliminary option volume…

SCSG

SouthCrest Financial Group

$0.00

(0.00%)

16:28
08/20/19
08/20
16:28
08/20/19
16:28
Hot Stocks
SouthCrest Financial Group announces $5M share repurchase pact »

SouthCrest Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.44

-0.42 (-1.14%)

16:25
08/20/19
08/20
16:25
08/20/19
16:25
Initiation
BP initiated  »

BP initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

ABBV

AbbVie

$66.38

-0.17 (-0.26%)

16:23
08/20/19
08/20
16:23
08/20/19
16:23
Hot Stocks
AbbVie VP Jeffrey Stewart buys over $1M in company shares »

AbbVie VP Jeffrey Stewart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.